Abstract
In their paper, Papantoniou et al. present relevant findings on the prevalence and characteristics of peripheral neuropathy in patients with myelodysplastic syndromes (MDS), underscoring the necessity for a more nuanced understanding of neurophysiological involvement in this complex haematological disorder. Their study not only reveals a higher frequency of neuropathy in MDS patients than previously reported but also illuminates specific neurophysiological patterns that may redefine clinical expectations and diagnostic practices in MDS-associated peripheral neuropathy. Commentary on: Papantoniou et al. Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes. Br J Haematol 2025; 206:864-867.